We are looking for Oncologists, Histopathologists, Consultant Clinical Scientists and Molecular Pathologists who have experience with the diagnosis and treatment of NTRK Fusion Cancers and patients with rare cancers that are NTRK Fusion positive. An in-depth interview will take place in London on the 11th of February and in Birmingham on the 12th of February. As for the rest of the UK, the methodology will be Telephone-Depth interview. Please log in or sign up below to apply for this study.
Les fiers membres et tenants de:
